StonvexLoading…
StonvexStonvexStonvexCore line items from MYPS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $56.47M | $58.41M | $235.10M | $179.69M | $122.05M |
Operating Income | Not available | $-13.30M | $-23.92M | $-14.09M | $-6.23M |
Net Income | Not available | $-10.68M | $-28.64M | $-14.95M | $-5.83M |
EPS (Diluted) | $-0.04 | $-0.08 | $-0.23 | $-0.12 | $-0.05 |
Total Assets | Not available | $282.43M | $290.62M | $299.15M | $316.23M |
Total Liabilities | Not available | $63.10M | $62.75M | $60.23M | $70.94M |
Cash & Equivalents | Not available | $103.68M | $104.94M | $106.32M | $112.86M |
Free Cash Flow OCF − CapEx | Not available | $3.65M | $25.37M | $21.76M | $16.41M |
Shares Outstanding | Not available | 127.66M | 125.68M | 125.47M | 125.35M |